Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vector induced humoral responses after rVSVΔG-ZEBOV-GP immunization identify vaccinated individuals and correlate with Ebola virus glycoprotein antibodies.
Chandrasekaran P, Berry IM, Callier V, Anthony SM, Hensley K, Kuhn JH, Shaw-Saliba K, Kennedy SB, Kieh M, Browne SM, Crozier I, Davey RT, Lane HC, Hensley LE, Follmann DA. Chandrasekaran P, et al. Among authors: hensley k. J Infect Dis. 2024 Dec 24:jiae632. doi: 10.1093/infdis/jiae632. Online ahead of print. J Infect Dis. 2024. PMID: 39718991
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.
Jongkees MJ, Tan NH, Geers D, de Vries RD, GeurtsvanKessel CH, Hensley KS, Sablerolles RSG, Bogers S, Gommers L, Blakaj B, Miranda Afonso P, Hansen BE, Rijnders BJA, Brinkman K, van der Kuy PHM, Roukens AHE, Rokx C. Jongkees MJ, et al. Among authors: hensley ks. AIDS. 2024 Jul 15;38(9):1355-1365. doi: 10.1097/QAD.0000000000003933. Epub 2024 May 28. AIDS. 2024. PMID: 38788210 Free PMC article.
See Thy Self.
Hensley K. Hensley K. S D Med. 2023 Oct;76(10):448. S D Med. 2023. PMID: 38232484 No abstract available.
SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models.
Gray E, Ulrich M, Epp A, Younan P, Sahetya D, Hensley K, Allred S, Huang LY, Hahn J, Gahnberg K, Treuting PM, Trueblood ES, Gosink JJ, Thurman R, Wo S, Spahr K, Haass EJ, Snead K, Miller D, Padilla M, Smith AJ, Frantz C, Schrum JP, Nazarenko N, Gardai SJ. Gray E, et al. Among authors: hensley k. J Immunother Cancer. 2023 Oct;11(10):e007572. doi: 10.1136/jitc-2023-007572. J Immunother Cancer. 2023. PMID: 37793853 Free PMC article.
A Case of Red Eye and Facial Swelling.
Victor-Linkenhoker V, Hensley K, Tavakoli T. Victor-Linkenhoker V, et al. Among authors: hensley k. Pediatr Rev. 2023 Oct 1;44(S1):S59-S62. doi: 10.1542/pir.2022-005737. Pediatr Rev. 2023. PMID: 37777235 No abstract available.
HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer.
Olson D, Taylor J, Willis K, Hensley K, Allred S, Zaval M, Farr L, Thurman R, Jain N, Hein R, Ulrich M, Peterson S, Kulukian A. Olson D, et al. Among authors: hensley k. Cancer Res Commun. 2023 Sep 25;3(9):1927-1939. doi: 10.1158/2767-9764.CRC-23-0302. Cancer Res Commun. 2023. PMID: 37721518 Free PMC article.
193 results